top of page

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...
JMG Logo transparent.png
Executive Spotlights

Kriya's Series C Surges to Over $430 Million

  • Aug 3, 2023
  • 1 min read

Palo Alto, CA, and Research Triangle Park, NC, July 26, 2023 (Globe Newswire) -- Kriya Therapeutics, Inc., a biopharmaceutical company pioneering transformation gene therapies in opthalmology, Neurology and metabolic disease, announced a $150 million infusion in its Series C Financing. This boost elevates the total Series C round to $430 million, reinforcing Kriya's commitment to transforming the lives of millions worldwide.


Read full article here.

 
 
 

Recent Posts

See All
Qlaris Bio Appoints Fred Guerard as CEO

Dedham, MA, March 1, 2026 (Business Wire) -- Qlaris Bio has appointed Fred Guerard, Pharm.D., as president and chief executive officer, effective March 1, 2026, and he will also join the company’s b

 
 
 

Comments


Life Science Headlines
bottom of page